发布: 2019年07月05日第9卷第13期 DOI: 10.21769/BioProtoc.3286 浏览次数: 5258
评审: Alessandro DidonnaLouise Jane WalportJane Antony
Abstract
Human pancreatic lipase (HPL) is the main lipolytic enzyme involved in the digestion of dietary fat. An active recombinant human pancreatic lipase (recHPL) was successfully prepared for the first time in an Escherichia coli (E. coli) expression system using a short Strep-tag II (ST II). The recHPL-ST II was solubilized with 8 M urea from the E. coli lysate and purified on a Strep-Tactin-Sepharose column. After refolding by stepwise dialyses against decreasing concentrations of urea in the presence of glycerol and Ca2+ for two days followed by gel filtration FPLC, 1.8-6 mg of active recHPL-ST II was obtained from 1 L of culture. Here we report the expression, purification, and optimized refolding procedures for active recHPL from E. coli, thus establishing it as a suitable system for the production of recHPL of high purity and scaling up.
Keywords: Human pancreatic lipase (人胰腺脂肪酶)Background
Mammalian lipase, essential for the dietary fat digestion and absorption, can be used for development of an anti-obesity treatment. However, obtaining pure and stable native mammalian lipase has been a challenge because it is often degraded by co-existing proteases in the pancreatic juice. Due to the limited availability of human tissue samples and their potential risk for disease transmission, it may be best to prepare HPL using recombinant expression systems. Several methods have been reported to express recHPL using yeast (Yang and Lowe, 1998), insect (Thirstrup et al., 1993), or mammalian cells (Canalias et al., 1994), which require culturing for at least 5, 6, or 10 days, respectively. The recHPLs obtained using these cells require strict quality control to achieve homogeneity because they are differentially glycosylated. The use of E. coli as an expression system can avoid these problems in addition to providing other benefits such as ease of culture and purification. Therefore, we have established a protocol for optimized expression, purification, and refolding of active recHPL from E. coli. This method requires only two days of culturing, is easy to scale up at low cost, and is convenient because it circumvents the need to control the glycosylation pattern of the recombinant protein. Although the recHPL is non-glycosylated and native porcine pancreatic lipase (PPL) is glycosylated, both lipases show lipolytic activity equal to native PPL against tributyrin and triolein as substrates (Kawaguchi et al., 2018). It may be useful as an alternative to the PPL that has been used in the development of pharmaceutical products. For example, pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency (Lowe and Whitcomb, 2015), and screening of inhibitor compounds to provide an important avenue for anti-obesity therapy (Seyedan et al., 2015). Other promising applications of recHPL are industrial biocatalysts for biotechnological processes (Sharma et al., 2001).
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Kawaguchi, N., Ogawa, H. and Date, K. (2019). Preparation and Purification of Active Recombinant Human Pancreatic Lipase in Escherichia coli. Bio-protocol 9(13): e3286. DOI: 10.21769/BioProtoc.3286.
分类
微生物学 > 异源表达系统 > 大肠杆菌
生物化学 > 蛋白质 > 表达
分子生物学 > 蛋白质 > 活性
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link